Gael Chételat
Gael Chételat
Researcher (Inserm, French institute for biomedical research)
Verified email at - Homepage
Cited by
Cited by
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease
JC Baron, G Chetelat, B Desgranges, G Perchey, B Landeau, ...
Neuroimage 14 (2), 298-309, 2001
Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?
G Chetelat, B Desgranges, V De La Sayette, F Viader, F Eustache, ...
Neurology 60 (8), 1374-1377, 2003
Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study
G Chételat, B Landeau, F Eustache, F Mézenge, F Viader, ...
Neuroimage 27 (4), 934-946, 2005
Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging
E Gerardin, G Chételat, M Chupin, R Cuingnet, B Desgranges, HS Kim, ...
Neuroimage 47 (4), 1476-1486, 2009
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease
N Villain, B Desgranges, F Viader, V De La Sayette, F Mézenge, ...
Journal of Neuroscience 28 (24), 6174-6181, 2008
Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment
G Chételat, B Desgranges, V De La Sayette, F Viader, F Eustache, ...
Neuroreport 13 (15), 1939-1943, 2002
Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging
G Kalpouzos, G Chételat, JC Baron, B Landeau, K Mevel, C Godeau, ...
Neurobiology of aging 30 (1), 112-124, 2009
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
Direct voxel-based comparison between grey matter hypometabolism and atrophy in Alzheimer's disease
G Chételat, B Desgranges, B Landeau, F Mézenge, JB Poline, ...
Brain 131 (1), 60-71, 2008
Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment
G Chételat, B Desgranges, V de la Sayette, F Viader, K Berkouk, ...
Brain 126 (9), 1955-1967, 2003
Discrimination between Alzheimer Disease, Mild Cognitive Impairment, and Normal Aging by Using Automated Segmentation of the Hippocampus1
O Colliot, G Chételat, M Chupin, B Desgranges, B Magnin, H Benali, ...
Radiology 248 (1), 194-201, 2008
Region-specific hierarchy between atrophy, hypometabolism, and β-amyloid (Aβ) load in Alzheimer's disease dementia
R La Joie, A Perrotin, L Barré, C Hommet, F Mézenge, M Ibazizene, ...
Journal of Neuroscience 32 (46), 16265-16273, 2012
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease
G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ...
NeuroImage: Clinical 2, 356-365, 2013
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
Imaging markers for Alzheimer disease: which vs how
GB Frisoni, M Bocchetta, G Chételat, GD Rabinovici, MJ De Leon, J Kaye, ...
Neurology 81 (5), 487-500, 2013
Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders
EM Arenaza-Urquijo, B Landeau, R La Joie, K Mevel, F Mézenge, ...
Neuroimage 83, 450-457, 2013
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
The default mode network in healthy aging and Alzheimer's disease
K Mevel, G Chételat, F Eustache, B Desgranges
International journal of Alzheimer’s disease 2011, 2011
Using PET with 18 F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
V Camus, P Payoux, L Barré, B Desgranges, T Voisin, C Tauber, ...
European journal of nuclear medicine and molecular imaging 39 (4), 621-631, 2012
The system can't perform the operation now. Try again later.
Articles 1–20